Clorox (NYSE:CLX) Announces Earnings Results

Clorox (NYSE:CLX) issued its quarterly earnings results on Monday. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16, RTT News reports. Clorox had a return on equity of 316.08% and a net margin of 4.78%. During the same period in the previous year, the business earned $2.16 earnings per share. Clorox updated its FY 2025 guidance to 6.950-7.350 EPS.

Clorox Trading Up 0.7 %

CLX traded up $1.12 during trading on Monday, hitting $159.80. 2,593,906 shares of the stock were exchanged, compared to its average volume of 1,136,242. The firm has a 50 day simple moving average of $162.76 and a 200 day simple moving average of $158.50. The firm has a market cap of $19.78 billion, a price-to-earnings ratio of 55.68, a P/E/G ratio of 2.92 and a beta of 0.42. Clorox has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.05%. Clorox’s payout ratio is currently 170.04%.

Analysts Set New Price Targets

A number of brokerages have commented on CLX. Evercore ISI reduced their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. JPMorgan Chase & Co. upped their price objective on Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a research note on Thursday, January 16th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Barclays dropped their price objective on Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research note on Friday, January 17th. Finally, Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and upped their price objective for the stock from $155.00 to $157.00 in a research note on Tuesday, January 7th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, Clorox currently has an average rating of “Hold” and an average target price of $156.07.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.